Evidence
What the product does, and how to prove it.
- Treatment protocols and indications
- Combination protocols with other products
- Design and review of clinical validation studies
Altior works with pharmaceutical and device companies in dermatology, aesthetics and surgery. We write the protocols, train the speakers and build the launch, so a product reaches the clinic with the evidence and the voice it needs.
Companies spend years on a molecule or a device and weeks on how physicians will use it. The indication is vague, the protocol is borrowed and the speaker was briefed the night before.
Physicians notice. Altior closes the distance between the product and the treatment room.
What the product does, and how to prove it.
Who speaks for the product, and how well.
How the product reaches physicians.
We identify two or three specific gaps in how the product is positioned, taught and used.
One product line, one or two markets, a closed scope and a result both sides can measure.
If the pilot delivers, we plan the year: evidence, speakers and launches, in that order.
Altior is founded and led by physicians who treat patients every week. We know how a product behaves in real practice because we use it.
The firm works from Uruguay and Brazil, with projects in Latin America and Europe. Strategy, production and digital development sit in one team, so the people who write the protocol also build the tools that teach it.
Altior is Latin for “higher”.
Write a few lines about the product, the markets and the launch date. We come back with questions before we come back with a proposal.